| Product Code: ETC7550326 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India Parkinson's disorder drugs market import shipment depicted a remarkable expansion with a robust CAGR from 2020 to 2024. Notably, the growth rate surged notably between 2023 and 2024, indicating accelerating momentum. The market exhibited a clear trend of significant growth over the specified period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Parkinsons Disorder Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Parkinsons Disorder Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Parkinsons Disorder Drugs Market - Industry Life Cycle |
3.4 India Parkinsons Disorder Drugs Market - Porter's Five Forces |
3.5 India Parkinsons Disorder Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Parkinsons Disorder Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Parkinsons Disorder Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Parkinsons Disorder Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in India |
4.2.2 Growing geriatric population in India |
4.2.3 Rising awareness about Parkinson's disorder and available treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with Parkinson's disorder drugs |
4.3.2 Limited access to healthcare facilities in remote areas |
4.3.3 Stringent regulatory requirements for drug approval in India |
5 India Parkinsons Disorder Drugs Market Trends |
6 India Parkinsons Disorder Drugs Market, By Types |
6.1 India Parkinsons Disorder Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Parkinsons Disorder Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Parkinsons Disorder Drugs Market Revenues & Volume, By Decarboxylase Inhibitors, 2021- 2031F |
6.1.4 India Parkinsons Disorder Drugs Market Revenues & Volume, By Dopamine Agonists, 2021- 2031F |
6.1.5 India Parkinsons Disorder Drugs Market Revenues & Volume, By Monoamine Oxidase Type B (MAO-B) Inhibitor, 2021- 2031F |
6.1.6 India Parkinsons Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Parkinsons Disorder Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Parkinsons Disorder Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 India Parkinsons Disorder Drugs Market Revenues & Volume, By Injection, 2021- 2031F |
6.2.4 India Parkinsons Disorder Drugs Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3 India Parkinsons Disorder Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Parkinsons Disorder Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 India Parkinsons Disorder Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.3.4 India Parkinsons Disorder Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 India Parkinsons Disorder Drugs Market Import-Export Trade Statistics |
7.1 India Parkinsons Disorder Drugs Market Export to Major Countries |
7.2 India Parkinsons Disorder Drugs Market Imports from Major Countries |
8 India Parkinsons Disorder Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for Parkinson's disorder drugs in India |
8.2 Adoption rate of advanced treatment options for Parkinson's disease |
8.3 Investment in research and development for new Parkinson's disorder drugs |
9 India Parkinsons Disorder Drugs Market - Opportunity Assessment |
9.1 India Parkinsons Disorder Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Parkinsons Disorder Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Parkinsons Disorder Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Parkinsons Disorder Drugs Market - Competitive Landscape |
10.1 India Parkinsons Disorder Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Parkinsons Disorder Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here